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The regulation of animal longevity shows remarkable plasticity, in that a variety of genetic
lesions are able to extend lifespan by as much as 10-fold. Such studies have implicated
several key signaling pathways that must normally limit longevity, since their disruption
prolongs life. Little is known, however, about the proximal effectors of aging on which these
pathways are presumed to converge, and to date, no pharmacologic agents even approach
the life-extending effects of genetic mutation. In the present study, we have sought to
define the downstream consequences of age-1 nonsense mutations, which confer 10-fold
life extension to the nematode Caenorhabditis elegans – the largest effect documented
for any single mutation. Such mutations insert a premature stop codon upstream of the
catalytic domain of the AGE-1/p110α subunit of class-I PI3K. As expected, we do not detect
class-I PI3K (and based on our sensitivity, it constitutes <14% of wild-type levels), nor do
we find any PI3K activity as judged by immunodetection of phosphorylated AKT, which
strongly requires PIP3 for activation by upstream kinases, or immunodetection of its prod-
uct, PIP3. In the latter case, the upper 95%-confidence limit for PIP3 is 1.4% of the wild-type
level. We tested a variety of commercially available PI3K inhibitors, as well as three phos-
phatidylinositol analogs (PIAs) that are most active in inhibiting AKT activation, for effects on
longevity and survival of oxidative stress. Of these, GDC-0941, PIA6, and PIA24 (each at 1
or 10µM) extended lifespan by 7–14%, while PIAs 6, 12, and 24 (at 1 or 10µM) increased
survival time in 5 mM peroxide by 12–52%. These effects may have been conferred by
insulinlike signaling, since a reporter regulated by the DAF-16/FOXO transcription factor,
SOD-3::GFP, was stimulated by these PIAs in the same rank order (PIA24>PIA6>PIA12)
as lifespan. A second reporter, PEPCK::GFP, was equally activated (∼40%) by all three.
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INTRODUCTION
Phosphatidylinositides are tightly regulated signaling molecules
that participate in a diverse range of cellular events, including
cell replication and survival, membrane trafficking, secretion,
adhesion, and cell migration (Boss and Im, 2012; Echard, 2012;
Mayinger, 2012). Phosphatidylinositol (PI; sometimes abbrevi-
ated as “PtdIns”) lipid chains are generally integrated into inner
cell membranes, while the attached phosphoinositide rings project
into the cytoplasm. PI’s are formed by additions of phosphate
to hydroxyl groups at the 1, 3, 4, and/or 5 position of the
inositol ring. Additions at the 3 position are governed by phos-
phatidylinositol 3-kinases (PI3K’s), enzymes with key regulatory
roles in cell division and metabolism (Wymann and Schultz,
2012). Class-I PI3K’s convert PI(4,5)P2 (often abbreviated as PIP2)
to PI(3,4,5)P3 (or PIP3), which plays decisive roles in multiple
signaling pathways.
Intracellular concentrations of l-α phosphatidylinositol 4,5-
bisphosphate (known as PI(4,5)P2, one of several PIP2 isoforms)
lie in the range of 2–30µM (Gambhir et al., 2004). Class-
I phosphatidylinositol 3-kinase (PI3K) can add phosphate to
PI(4,5)P2 at the inositol 3 carbon to form phosphatidylinositol
3,4,5-triphosphate[PI(3,4,5)P3 or PIP3]. This key signaling mol-
ecule or “second messenger” is normally present at only ∼0.1%
of the levels of its precursor (Weinkove et al., 2006), or <30 nM.
In response to stimuli, however, the concentration of PIP3 can
increase up to 100-fold (Pettitt et al., 2006), achieved through
activation of PI3K and/or inactivation of the opposing PI 3-
phosphatase, PTEN. Many membrane-associated proteins, includ-
ing a number of kinases involved in signal transduction cascades,
have a domain that binds either PIP3 or a specific PIP2. The best-
studied of these are Pleckstrin Homology (PH) domains, typically
∼120 amino-acid residues long, many of which show quite specific
affinity for PIP3. In the insulin signaling pathway, formation of
PIP3 is required for the downstream activation of AKT/PKB, a pro-
tein kinase that promotes cell proliferation and blocks apoptosis in
many cell types (Franke et al., 1997). In order to be activated, AKT
must bind PIP3 at its PH domain. This tethers AKT to the inner
cell membrane, in relative proximity to its upstream kinase(s) and
downstream targets, while also inducing a structural change in
AKT to expose a key phosphorylation site to activating kinases such
as PDK-1 (Stokoe et al., 1997). Mammalian AKTs are fully active
when phosphorylated at residues Thr308 and Ser473 (Stokoe et al.,
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1997); other AKT-activating kinases include DNA-dependent pro-
tein kinase (DNA-PK) (Dragoi et al., 2005; Sester et al., 2006)
and TOR complex (Hawkins et al., 2006). Following dimerization,
AKT1/AKT2 complex phosphorylates dozens of targets, includ-
ing kinases and transcription factors, leading to their activation
or inactivation (Cutillas et al., 2006). FOXO transcription fac-
tors (DAF-16 isoforms in Caenorhabditis elegans) are among the
inactivated targets, as their phosphorylation by the AKT complex
prevents their entry into the nucleus (Tissenbaum and Ruvkun,
1998; Berdichevsky et al., 2006). AKT mutations conferring con-
stitutive activation are observed in many cancers (Shtilbans et al.,
2008); mutations in the pten gene, disrupting the PI 3-phosphatase
that opposes PI3K, also produce a high PIP3/PIP2 ratio, favor-
ing activated AKT and hence cell proliferation in diverse cancers
(Yi et al., 2005). Although direct constitutive activation of PI3K
is far less common, the BCR-ABL fusion protein indirectly acti-
vates PI3K, thus elevating PIP3 in chronic myelogenous leukemia
(Kharas et al., 2008).
The above findings demonstrate the critical involvement of
PIP3/AKT/FOXO signaling in cell proliferation, and have led to
great interest in disruption of such signaling in cancers (Castillo
et al., 2004). However, this kinase cascade has also been implicated
in other roles beyond cell proliferation. Enhanced PIP3 signaling
in specific hypothalamic neurons is associated with diet-sensitive
obesity (Plum et al., 2006). Lithium, commonly used as a mood
stabilizer for bipolar disorder, suppresses PIP3 signaling in Dic-
tyostelium and in cultured human cells (King et al., 2009). To date,
attention has been largely focused on drugs that target PI3K or
AKT. The two PI3K inhibitors in most common use are LY294002
and wortmannin (Vlahos et al., 1994; Schultz et al., 1995; Semba
et al., 2002). These drugs bind to the ATP-binding site of PI3K,
LY294002 reversibly (IC50 0.5–10µM) and wortmannin much
more avidly (IC50 7 nM)(Wu et al., 2008). Both are known to
inhibit other kinases (e.g., PLK1) with similar IC50 values; in
view of the thousands of proteins with ATP-binding sites, such
off-target effects are not surprising. A number of PI3K inhibitors
have been developed through small-molecule screens or by syn-
thetic chemistry testing derivatives of partially effective molecules.
Among these, ZSTK474 inhibits p110γ somewhat more than α or
β (IC50’s of 6, 17, and 53 nM respectively); whereas A66 is rather
specific for p110α (IC50 of 32 nM), requiring >3µM to reach the
IC50 against β or γ. The most avid p110α inhibitor is GDC-0941
with an IC50 of 3 nM, but its activity against other PI3K isoforms
has not been reported. In another approach, phosphatidylinositol
analogs (PIAs) were designed to dock in the PIP3-binding (PH)
domain of AKT and thereby inhibit its activity (Kozikowski et al.,
2003). It is not known whether any of these compounds have
affinity for the PIP2-binding catalytic site of PI3K.
The C. elegans age-1 gene encodes the nematode homolog of
p110α, the mammalian class-I or -Iα catalytic subunit of PI3K
(Morris et al., 1996) responsible for conversion of PIP2 to PIP3.
Nonsense mutants of age-1, at the second homozygous genera-
tion, should lack any active PI3K. These worms are extremely
long-lived and resistant to multiple stresses; they develop very
slowly and are completely infertile, reflecting severely impaired
cell division (Ayyadevara et al., 2008). Those phenotypes were
largely blunted in the first homozygous generation, presumably
due to carry-over of oocyte PI3K, age-1 mRNA, or PIP3 from their
age-1-heterozygous parent.
Because PIP3 can allosterically alter the conformation of a PH-
domain protein, permitting its activation by one or more kinases,
PIP3 may serve as a catalyst for that activation and be required
only in minute amounts. In contrast, it is required continuously
(and hence stoichiometrically) for its membrane-tethering role.
We therefore predict that, over most of its physiological range of
concentration, PIP3 will have an essentially linear dose-response
curve with respect to activity of any individual PIP3-binding pro-
tein (although it would become non-linear for any process that
depends on several such proteins). However, for binding proteins
that also depend on PIP3 “catalytically,” such as AKT, a far more
dramatic effect might be expected on removal of the last few PIP3
molecules per cell – perhaps accounting for the marked pheno-
typic differences between first- and second-generation age-1-null
homozygotes (Ayyadevara et al., 2008).
We have now examined PIP3 levels by quantitative immuno-
fluorescence as well as functional assays, in first and second-
generation age-1(mg44) homozygotes, comparing them to worms
that bear wild-type or weaker age-1 mutant alleles. We also have
asked whether PI3K inhibitors can partially “phenocopy” age-1
mutation in wild-type animals, to enhance longevity and stress
tolerance.
RESULTS
PI3K IS WIDELY DISTRIBUTED IN WILD-TYPE C. ELEGANS, BUT IS NOT
DETECTED OVER BACKGROUND IN age-1-NULL MUTANT WORMS
The age-1(mg44) allele encodes a truncated PI3K p110α protein,
due to replacement of the Trp codon at position 387 (of 1146) by
an amber stop codon (Ayyadevara et al., 2008). Antibody raised to
the helical and kinase domains of AGE-1, lying downstream of (C-
terminal to) the mutation, registered full-length enzyme as a dif-
fuse cytoplasmic signal in virtually all cell types of wild-typeC. ele-
gans adults (Figures 1A,C). The same antibody, however, failed to
detect AGE-1 protein in second-generation age-1(mg44) homozy-
gotes, over the background seen in wild-type worms exposed only
to the fluorescent secondary antibody (Figures 1B,C).
PIP3 IS SIGNIFICANTLY REDUCED IN FIRST-GENERATION age-1(mg44)
HOMOZYGOTES, AND IS BELOW DETECTABLE LIMITS IN THEIR
SECOND-GENERATION PROGENY
Despite the absence of full-length, catalytically active AGE-1 pro-
tein, it is possible that PIP3 might be generated by a PI3K p110
of a different class, or via an alternative biosynthetic pathway.
We therefore assessed PIP3 levels, initially and most sensitively by
in situ immunofluorescence but with confirmation by activity-
based assays. Using a highly specific antibody against PIP3 (Chen
et al., 2002; Kharas et al., 2008), we found that age-1(mg44)
second-generation homozygotes have no PIP3-specific immuno-
fluorescence above background, i.e., their level is indistinguishable
from negative control samples from which the primary antibody
was omitted (Figure 2). In several replicate experiments com-
paring groups of day-8 adults (of which Figure 2 is typical), we
observed 15–25% reductions in PIP3 signal for worms carrying the
weaker hx546 allele of age-1 (each P < 0.001 compared to wild-
type), 60–75% reductions for first-generation mg44 homozygotes
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FIGURE 1 | Immunodetection of AGE-1 protein (class-I PI3K catalytic
subunit) in adult C. elegans of wild-type strain N2DRM (A) or
second-generation age-1(mg44) homozygotes at adult age 3 days
(B). Synchronized worms, fixed 14 h in 1% formaldehyde at 4˚C, were
permeabilized by successive exposures to 1% β-mercaptoethanol,
10-mM DTT, and 0.3% hydrogen peroxide. Primary antibody was goat
anti-AGE-1 at1:50 (Santa Cruz Biotech.), followed by rabbit anti-goat
ALEXA680-tagged IgG at 1:200 (Invitrogen), imaged on an Olympus
BX51 fluorescence microscope at 10×. The histograms (C) show mean
fluorescence intensity, ±SEM, in two independent experiments. Each
includes a negative control, staining of wild-type worms without primary
antibody (rightmost bar).
(each P < 10−12), and essentially no signal above background in
second-generation mg44/mg44 adults (P < 10−12 relative to any
group except negative controls). Because the upper bound of the
95% confidence interval for these “F2”mg44−/− worms is∼1.4%
of the wild-type level, we infer that their PIP3 level is reduced
at least 70-fold relative to wild-type adults. PIP3 levels were also
assessed at several ages. Wild-type N2 worms showed maximal sig-
nal at 3 days of adult age (coinciding with peak fecundity) and fell
to 35–40% of maximum at 6–10 days, whereas second-generation
mg44 homozygotes never differed significantly from background
at adult ages 3, 5, or 10 days (data not shown).
Activity-based assays were used to confirm immunofluores-
cence quantitation of class-Iα PI3K, and of PIP3. PI3K activity
is difficult to quantify in unstimulated cells, in which it is below
the limits of detection, but it can be measured after induction
by oxidative stress (Weinkove et al., 2006). We induced oxidative
stress by exposing adult worms to 4 mM H2O2 for 40 min at 20˚C,
in the presence of 32PO=4 . Worms were then lysed and their PIP’s
isolated and resolved by thin-layer chromatography. PI3K activity
was calculated as the ratio of 32P incorporation coinciding with
the position of a PIP3 standard, to 32P signal migrating with PIP2.
As expected, no PIP3 signal was detected in the absence of peroxide
stress. After H2O2 exposure, it reached a measurable level (a ratio
of 0.07) only for wild-type worms, but remained near-zero for
worms carrying either age-1 allele (Figure 3).
Similarly, we were able to confirm PIP3 depletion in age-
1(mg44) second-generation homozygotes, using a functional assay
based on the requirement for PIP3-binding to bioactivate AKT
via phosphorylation at Thr308 (Stokoe et al., 1997). Antibodies
recognizing unphosphorylated human AKT, or specific for AKT
phosphorylated at Thr308, were used to evaluate the products of
incubating bacterially synthesized human AKT with C. elegans
lysates (Figure 4). The results support our immunofluorescence
data, indicating the virtual absence of any PIP3 in the very long-
lived mg44-mutant worms, relative to wild-type. Dependence
of the assay on endogenous PIP3 was demonstrated by adding
synthetic PIP3 (Figure 4, rightmost bar).
NEMATODE LIFESPAN AND PEROXIDE RESISTANCE ARE MODESTLY
ENHANCED BY SEVERAL PI3K INHIBITORS, IN PARTICULAR
PHOSPHATIDYLINOSITOL ANALOGS
We tested a variety of PI3K inhibitors for the ability to extend
nematode lifespan, in effect seeking a partial “pharmacopy” of
the age-1 phenotype. Neither wortmannin, LY294002, A66, nor
www.frontiersin.org March 2013 | Volume 4 | Article 34 | 3
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FIGURE 2 | Immunofluorescence quantitation of PIP3 in C.
elegans. Worms were permeabilized as for Figure 1 and incubated
with mouse antibody to PIP3 (Echelon), followed by a 1:200 dilution of
secondary antibody, ALEXA594-labeled goat anti-mouse IgG
(Invitrogen). Images (A–D), acquired on an Olympus BX51
microscope, were quantified with ImageJ and summarized in (E) for a
typical experiment. Histogram bars show means±SEMs for 20–50
worms per group. Background, assessed without primary antibody, is
shown (rightmost bar) but has not been subtracted. Worm ages are
given in days (d) as adult.
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FIGURE 3 | In vivo 32P-labeling of PIP2 and PIP3. Young adult worms were
washed and incubated 16 h in phosphate-free medium to which 0.6 mCi
32PO4 were added. Where indicated, worms were exposed 45 min to
16-mM H2O2; lipids were extracted, chromatographed, and
autoradiographed. Quantitative results (PIP3 as a percent of the sum of PIP2
and PIP3), determined by scintillation counting of excised spots, are given
above the TLC image.
ZSTK474 (each tested at 1–10µM) increased the lifespan of
wild-type worms (Table 1), However, GDC-0941 – reportedly
the most avid p110α inhibitor – at 1µM extended lifespan by
10% (nominally significant, Gehans–Wilcoxon P < 0.03). We then
tested four phosphatidylinositol analogs (PIAs) previously shown
to be potent inhibitors of signal transduction via AKT activation
(Gills et al., 2006, 2007; Memmott et al., 2008). PIA6 and PIA24
increased adult life span in two of three repeats, relative to PIA7
(inactive control) or DMSO vehicle-treatment. In the experiment
shown (Figure 5), mean longevity was extended 10% (P < 0.05)
FIGURE 4 | Functional assay of PIP3 based on phosphorylation of
AKT(Thr308). Bacterially synthesized AKT, with an N-terminal His6 tag, was
added to cleared C. elegans lysates, and after 1 h at 20˚C, was bound to
AKT monoclonal antibody on AlphaBeads (PerkinElmer) in an AlphaScreen
PI3K Assay (Echelon), and scored for also binding a tagged antibody to
AKT(P-Thr308). Results were read on an Envision 2104 Microplate Reader
(PerkinElmer). Error bars are standard deviations (N =3).
by PIA6, and nearly 14% by PIA24 (P < 0.015, Gehans–Wilcoxon
log-rank test; Table 2).
We then compared PIAs 6, 12, and 24 to LY294002 or an inac-
tive PIA, for their ability to extend survival of C. elegans exposed
to a lethal oxidative stress, 5 mM hydrogen peroxide. PIAs 6 and
24 again conferred the greatest protection to wild-type worms,
extending survival by 18 and 19%, respectively (each P < 10−6),
while PIA12 initially increased peroxide survival 12% (P < 0.003)
and LY294002 by <1% (NS) relative to controls (Figure 6A;
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Table 1 | Effects of PI3K inhibitors on wild-type lifespan at 25˚C.
DMSO LY294002 Wortmannin A66 GDC-0941 ZSTK474
1µM 1µM 1µM 1µM 1µM
Mean survival (days) 10.72 10.51 10.28 9.78 11.64 10.96
SD 2.31 2.66 2.91 2.26 2.32 2.24
SEM 0.31 0.55 0.69 0.49 0.42 0.41
N 54 23 17 22 30 29
% Of DMSO control 98.0 95.9 91.2 109.6 102.2
P , Gehans–Wilcoxon – – – – <0.03 –
10µM 10µM 10µM 10µM 10µM
Mean survival (days) 9.80 10.83 9.97 10.97 9.60
SD 2.62 2.34 2.20 2.03 1.97
SEM 0.57 0.52 0.49 0.45 0.40
N 21 20 21 20 24
% Of DMSO control 91.4 101.0 93.0 102.3 89.6
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FIGURE 5 | Longevity survivals of wild-type (N2DRM) C. elegans
maintained at 20˚C on plates with phosphatidylinositol analogs (PIAs).
Worms from synchronous cultures were selected as L4 larvae, and placed
on 10-cm agar plates containing 1µM of either PIA6, PIA24, or an inactive
control, PIA7. They were transferred daily to identical plates on days 1–7 of
adulthood to isolate them from their progeny, and transferred every
2–3 days thereafter. At each transfer, worms were scored as dead if they
failed to move either spontaneously or in response to gentle prodding.
Worms dying from desiccation due to stranding on the side walls of dishes,
or from internal hatching of progeny, were censored at the midpoint of
transfers between which death was discovered.
Tables 3A,B). In these experiments, PIAs generally conferred less
(and less significant) protection to age-1(hx546) worms, although
PIA12 appeared equally effective for either strain (Figure 6B;
Tables 3A,B). When newly synthesized batches of PIAs 6 and 12
were subsequently tested (Tables 3C,D), PIA12 was more protec-
tive than PIA6, indicating that differences in these analogs may
in large measure reflect purity and freshness of the compounds.
LY294002 was only moderately effective at doses ranging from 1 to
20µM, whereas the tested PIAs remained equally protective from
1 to 1000µM (Table 3 and additional data not shown).
Table 2 | Effects of PIAs on wild-type (N2) lifespan at 20˚C.
DMSO PIA7 PIA6 PIA24
1µM 1µM 1µM
EXPERIMENT 1
Mean survival (days) 18.8 19.2 20.3 20.5
SD 2.8 2.7 1.8 2.3
SEM 0.63 0.56 0.36 0.47
N 19 24 26 24
% (DMSO+PIA7)/2 – – 106.8 108.0
P , Gehans–Wilcoxon – – <0.10 <0.03
EXPERIMENT 2
Mean survival (days) 17.3 16.6 18.2 18.8
SD 3.2 4.6 3.8 2.5
SEM 0.40 0.63 0.72 0.45
N 64 52 28 32
% (DMSO+PIA7)/2 – – 109.9 113.5
P, Gehans–Wilcoxon – – <0.06 <0.015
Combined Signif.: <0.006 <0.0004
PIP3 ANALOGS INDUCE GENES THAT ARE POSITIVELY REGULATED BY
INSULIN/IGF-1 SIGNALING
DAF-16 target genes such as those encoding SOD-3 and PEPCK are
strikingly upregulated in age-1(mg44) worms, and somewhat less
so in age-1(hx546) mutants – increases that are blocked when daf-
16 is deleted (Shmookler Reis et al., 2009; Tazearslan et al., 2009).
The DAF-16 transcription factor was shown to mediate strong
modulation of expression (by factors of 2 to >1000) by the age-1
allele for a total of 64 genes (Ayyadevara et al., 2009; Tazearslan
et al., 2009). SOD-3 is an Fe++/Mn++ superoxide dismutase,
believed to be mitochondrial and to protect against superoxide
produced via the electron-transport chain; its mRNA is upregu-
lated>9-fold in age-1(mg44)-F2 worms (Tazearslan et al., 2009). If
PIA treatment, like age-1 mutations, disrupts insulinlike signaling
through DAF-16 activation, it should enhance transcription of sod-
3. We treated young adult worms expressing a SOD-3::GFP fusion
protein with several PIAs, each at 1µM concentration. PIA24
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Table 3 | Protection against 5-mM peroxide by PI3K inhibitors at 20˚C.
A. EXPERIMENT 1
DMSO PIA7 LY294002 PIA6 PIA12 PIA24
1µM 1µM 1µM 1µM 1µM
N2, wild-type
Mean survival (h) 6.8 6.6 6.7 7.9 7.5 8.0
SD 0.7 0.7 0.6 0.7 1.0 2.2
SEM 0.15 0.16 0.13 0.16 0.23 0.41
N 20 20 20 20 20 22
% of PIA7 control – – 101 118 112 119
P, Gehans–Wilcoxon – – N.S. <1E–6 0.002 <1E–6
Age-1(hx546)
Mean survival (h) 9.8 10.8 10.0 11.0 9.6
SD 2.6 2.3 2.2 2.0 2.0
SEM 0.57 0.52 0.49 0.45 0.40
N 21 20 21 20 24
% of PIA7 control – 96.5 116 112 112
P, Gehans–Wilcoxon – N.S. 0.0008 0.005 0.009
B. EXPERIMENT 2
PIA7 LY294002 PIA6 PIA6 (10µM) +
10µM 10µM 10µM LY294002 (10µM)
N2, wild-type
Mean survival (h) 6.0 7.1 7.1 7.5
SD 1.0 1.5 1.1 1.4
SEM 0.15 0.24 0.17 0.23
N 40 40 40 40
% of PIA7 control – 118 118 125
P, Gehans–Wilcoxon – <1E–3 <1E–5 <1E–6
Age-1(hx546)
Mean survival (h) 8.3 8.6 9.0 9.0
SD 1.5 1.2 1.0 1.1
SEM 0.23 0.19 0.16 0.17
N 40 40 40 40
% of PIA7 control – 103 107 107
P, Gehans–Wilcoxon – NS <0.04 <0.05
C. EXPERIMENT 3
PIA7 PIA6 PIA12 PIA6+LY PIA12+LY
1µM 1µM 1µM 1µM, 10µM 1µM, 10µM
N2, wild-type
Mean survival (h) 6.9 8.6 10.0 8.6 8.5
SD 1.6 1.6 1.1 1.7 1.7
SEM 0.25 0.25 0.17 0.26 0.27
N 40 40 40 40 40
% of PIA7 control – 124 144 124 122
P, Gehans–Wilcoxon – <1E–5 <1E–12 <1E–4 <1E–4
D. EXPERIMENT 4
PIA7 PIA6 PIA12 PIA7+LY PIA6+LY PIA12+LY
1µM 1µM 1µM 1µM, 10µM 1µM, 10µM 1µM, 10µM
N2, wild-type
Mean survival (h) 6.2 7.3 9.4 6.4 7.4 7.4
SD 1.32 1.5 1.2 1.4 1.8 1.6
SEM 0.30 0.33 0.28 0.32 0.40 0.35
N 20 20 20 20 20 20
% of PIA7 control – 118 152 103 119 118
P, Gehans–Wilcoxon – <0.02 <1E–8 0.65 <0.04 <0.02
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FIGURE 6 | Survival time during exposure to a toxic level of hydrogen
peroxide, after development and growth in the presence of PIAs or
LY294002. Adult worms (day 2–3 after the L4/adult molt) of strain N2DRM
[(A), wild-type] or age-1(hx546 ) [(B), a moderately long-lived age-1 mutant]
were maintained from hatching on 1µM of LY294002 (a widely used
inhibitor of class-I PI3K); PIA6, PIA12, or PIA24 (active PIP3 analogs); PIA7
(inactive control analog); or their common solvent, DMSO (added in the
amount transferred with the inhibitors). Worms at adult day 3 were
transferred to liquid medium without bacteria, containing 5 mM hydrogen
peroxide, and were then monitored hourly for survival as described in the
Figure 5 legend.
increased SOD-3::GFP levels by 26% after 48 h (P < 0.0002),
chiefly affecting diffuse global expression, whereas PIA6 and PIA12
produced increases of only 9% (P < 0.05) and 6% (not signifi-
cant) respectively, while LY294002 slightly reduced fluorescence
(Figure 7, panels A–E,K). We tested putative PI3K inhibitors
for effects on pck-2, the daf-16 target gene encoding phospho-
enolpyruvate carboxykinase (PEPCK), which is upregulated>8.5-
fold in age-1(mg44)-F2 worms (Tazearslan et al., 2009). PEPCK
is a key enzyme of metabolic regulation which extends lifespan
and increases physical activity levels as well as metabolic rate
when overexpressed in mice (Hakimi et al., 2007). Adult worms
expressing a PEPCK::GFP fusion protein were treated with 1µM
LY294002 or PIAs for 48 h. LY294002 increased PEPCK::GFP fluo-
rescence by 25% (P < 0.01 relative to PIA7 controls), while PIAs 6,
12, and 24 elicited increases of 39–41% (each P < 0.002; Figure 7,
panels F–J,L).
DISCUSSION
Since age-1(mg44) F2-homozygous worms show no full-length
PI3K catalytic subunit, it does not appear to be synthesized by
either alternative-splicing or read-through routes that avoid the
mutationally introduced stop codon. We note that the expres-
sion of other components of insulin/IGF-1 signaling are also
suppressed at the transcript level in this strain, as are catalytic
subunits for all three classes of PI3K (Tazearslan et al., 2009).
This underscores the point that the unique survival phenotypes
associated with this mutant may not derive entirely from direct
effects of the age-1 nonsense mutation, but may instead be indirect
consequences.
These worms evidence no measurable PI3K activity, even when
strongly induced by peroxide stress in a transiently starved state.
Although measures of PI3K activity averaged zero, such negative
findings (no detectable class-I PI3K enzyme or activity) are con-
strained by the limited sensitivity of the assays, to the rather weak
conclusion that F2 mg44−/− worms have significantly less than
half or one-fifth as much activity as wild-type (Figure 1C, left
and right panels, respectively). In the PIP3 immunoassay, however,
the F2 mutant level had such a small variance that it was signifi-
cantly below 1.4% of the wild-type value. In contrast, their “F1”
homozygous parents had 40% of wild-type PIP3 levels, which was
far more than F2 progeny possessed (P < 10−15). These results are
consistent with the hypothesis of maternal protection, wherein F1-
homozygous worms acquire significant amounts of age-1 mRNA,
AGE-1 protein, and/or PIP3, from the oocytes formed in their het-
erozygous mothers. The hx546 worms show higher levels of PIP3
than age-1 F1 or F2 worms, suggesting that they retain substantial
kinase activity despite our failure to detect any by PI3K activ-
ity assay (Figure 3). Given that strong age-1 mutation indirectly
suppresses transcription of pten, encoding the PTEN phosphatase
that opposes AGE-1/PI3K (Tazearslan et al., 2009), it is possible
for steady-state PIP3 levels to be reduced far less, in either age-1
mutant, than PI3K itself.
We next determined the downstream consequences of chem-
ical treatments thought to disrupt insulin/IGF-1 signaling, by
monitoring global expression of SOD-3::GFP and PEPCK::GFP
transgenic fusion proteins. The three active PIAs were of similar
efficacy in stimulating PEPCK::GFP expression (Figure 7), and
each was more effective than LY294002. When SOD-3::GFP fluo-
rescence was assessed, however, LY294002 was actually inhibitory,
and PIA24 was substantially more effective than either of the other
PIAs. Since both sod-3 and pepck are targets of the same FOXO
transcription factor, DAF-16, it appears incongruous that the spec-
trum of drug activities should differ for these two endpoints.
However, the tissue distribution differs between SOD-3 (globally
expressed, with highest expression at the anterior tip, followed
by the nerve ring just posterior to that, very similar to Worm-
Base Expr8145 and Expr3925) and PEPCK (PCK-2, Expr6502
in WormBase: seen in adult intestine, reproductive organs, and
vulval muscle, with lower expression in body-wall muscle); see
Figure 7. Perhaps of even greater importance is the likelihood
of multiple drug targets which differ among the PIAs (Gills
et al., 2007). Differences between PIAs and more conventional
PI3K inhibitors such as LY294002 are also expected, since PIAs
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FIGURE 7 | PIAs induce elevated expression of known insulinlike
signaling reporters, SOD-3:: GFP, and PEPCK::GFP. Worms with integrated
sod-3::gfp and pepck::gfp reporter constructs were grown 3 days in medium
containing 1µM PIA6, PIA12, or PIA24 (active PIP3 analogs); PIA7 (inactive
control analog); or LY294002 (an inhibitor of class-I PI3K). Reporter
fluorescence was then imaged with a 10× objective and quantified using
ImageJ. (A–E), Fluorescence images of worms at 3 days of adult age,
expressing SOD-3::GFP, after exposures as indicated. (F–J), Fluorescence
images of worms at 3 days of adult age, expressing PEPCK::GFP, after
exposures as indicated. Bars in images indicate 200µm. Note that the
SOD-3::GFP images are shown at slightly greater magnification than the
PEPCK::GFP images. (K), Histogram of mean±SEM fluorescence for 10–20
worms per group, expressing SOD-3::GFP. (L), Histogram of mean±SEM
fluorescence for 10–20 worms per group, expressing PEPCK::GFP. Statistical
significances indicated for specific inter-group comparisons were calculated
by two-tailed t -tests without adjustment for multiple comparisons.
were designed to target the PIP3-binding site of AKT [and may
also target other PIP3-binding sites (Gills et al., 2007) includ-
ing that of PI3K], whereas LY294002, wortmannin, and many
other PI3K inhibitors, instead target the ATP-binding pocket of
the PI3K catalytic subunit (Walker et al., 2000). It is thus quite
possible that “collateral targets” of these drugs differ among tis-
sues, and some of these targets may interact differentially with
SOD-3 vs. PEPCK reporters. We note that such unintended
drug targets might include effects on translation and protein
turnover components, which could then influence expression of
reporters.
These same drugs also varied with respect to protection of
N2 adults from peroxide stress (Figure 6). For a given synthe-
sis, they followed the same rank order (PIA24>PIA6>PIA12)
as lifespan and the induction of SOD-3, which contributes to
oxidant protection. The age-1(hx546) mutation only blunted the
protection by PIA24 to approximately the same level as PIA12
(Figure 6B), which may be explicable if PIA24 confers part of
its oxidative stress resistance through interaction with AGE-1,
whereas the other PIAs act entirely via AGE-1-independent mech-
anisms (e.g., interaction with AKTs). LY294002 provided little or
no benefit to either lifespan or peroxide survival; indeed, of all
the drugs (other than PIAs) previously reported to inhibit PI3K,
only GDC-0941 produced a nominally significant increase in C.
elegans longevity, i.e., P < 0.03 without adjustment for multiple
endpoints (Table 1). The absence of any short-term toxicity (or
increased susceptibility to peroxide stress), for PIAs across a 1000-
fold dose range, argues against a mechanism involving hormesis
via deleterious drug effects. It remains to be seen whether drugs
can be developed with greater specificity for class-I PI3K cat-
alytic subunit, and whether those drugs will better recapitulate
the extreme longevity and oxidative stress resistance of strong
age-1-null mutations.
MATERIALS AND METHODS
STRAINS
Nematode strains were supplied by the Caenorhabditis Genet-
ics Center (CGC, Minneapolis) and were maintained at 20˚C
Frontiers in Genetics | Genetics of Aging March 2013 | Volume 4 | Article 34 | 8
Bharill et al. PIP3 depletion in extreme longevity
on 0.6% peptone NGM-agar plates seeded with E. coli strain
OP50, as described (Ebert et al., 1993; Ayyadevara et al., 2001;
Shmookler Reis et al., 2007). Cohorts were synchronized by
alkaline hypochlorite lysis of parents (sparing eggs/larvae), and
propagated on fresh nutrient-agar plates (Sulston and Hodgkin,
1988).
DETERMINATION OF LIFE SPAN
Nematodes, grown on NGM-agar plates containing 0.6% peptone,
were harvested by rinsing off each plate with S buffer (0.1 M NaCl,
0.05 M potassium phosphate, pH 6.0) (Sulston and Hodgkin,
1988). Adults were allowed to settle, and then resuspended in
alkaline hypochlorite (0.5 N NaOH, 1.05% hypochlorite; 5 min
at 20˚C). The recovered eggs (containing unenclosed larvae) were
rinsed in S buffer and placed on fresh agar plates seeded with
E. coli strain OP50. Survival cultures were established on 60-
mm NGM-agar plates (Sulston and Hodgkin, 1988; Ebert et al.,
1993; Ayyadevara et al., 2003) seeded with OP50. PI3K inhibitors,
including LY294002, wortmannin, A66, ZSTK474, and GDC-0941
(Selleckchem, Houston, TX, USA) or phosphatidylinositol analogs
(PIAs, from A. Kozikowski, University of Illinois, Chicago) dis-
solved in DMSO, were overlaid on plates to achieve final con-
centrations of 1, 2, or 10µM. Worms were added 6 h later, 1 day
after the L4/adult molt; 30–50 adults were transferred to each 60-
mm dish. Worms were maintained at 20˚C, and scored as alive,
dead, or lost during daily transfer to fresh dishes. Worms were
considered dead if they did not move either spontaneously or in
response to touch; those lost (stranded on dish walls or beneath
the agar) or killed by internal hatching of progeny (“bagging”)
were censored at the midpoint of the time interval in which this
occurred; worms inadvertently killed were censored at the time of
the event.
HYDROGEN PEROXIDE STRESS TOLERANCE AFTER PIA TREATMENT
Adult worms [N2DRM or age-1(hx546), as indicated] were syn-
chronized by alkaline hypochlorite lysis of hermaphrodites; sur-
viving embryos were transferred to fresh NGM-agar plates and
allowed to mature. On reaching the L4 stage, worms were placed
on fresh NGM-agar plates seeded with OP50 and overlaid with
PIAs to achieve 1µM. After 48 h, they were transferred to 24-
well plates (20–25 worms per well) containing S medium (S
buffer plus 0.5% cholesterol) and 5- or 7-mM hydrogen per-
oxide (Sigma) at 20˚C, as previously described (Ayyadevara
et al., 2005, 2008). Survival was scored as above, initially at 1-
h intervals, until no worms remained alive. Assays, each com-
prising 20 or 40 worms, were performed two to six times per
strain.
PIP3 STAINING AND IMMUNOFLUORESCENCE
N2DRM, age-1(hx546), and age-1(mg44) worms were fixed at
indicated ages by a modified Finney–Ruvkun protocol (Finney
and Ruvkun, 1990). Briefly, worms were rinsed from plates in S
buffer, rinsed again, and fixed at room temperature in S buffer
containing 1% formaldehyde. The solution was frozen on dry ice
and thawed overnight at 4˚C with slow agitation. After centrifuga-
tion, 30 s at 2000 rpm, supernatant was aspirated and worms were
washed twice with Tris-Triton buffer (“TTB,” comprising 0.1 M
Tris-Cl, pH 7.4; 10 mM EDTA; and 1% v/v Triton X-100), then
incubated 2.5 h at 37˚C in TTB plus 1% w/v β-mercaptoethanol
to reduce disulfide bonds. Worms were washed twice in 25-mM
borate buffer, pH 9.2, incubated 15 min at 37˚C with borate plus
10- mM DTT, and exposed 15 min at 20˚C to 0.3% H2O2 in borate
buffer. After rinsing in antibody B buffer [0.14 M NaCl; 50-mM
sodium phosphate buffer, pH 7.9; 0.1% w/v bovine serum albu-
min (BSA); 0.1% v/v Triton X-100; 10-mM EDTA; and 0.05%
w/v NaN3], they were incubated at 4˚C overnight with mouse
IgM antibody to PI(3,4,5)P3 (Echelon Biosciences Inc.) diluted
1:50 in antibody A buffer (identical to B buffer but with 1% w/v
BSA). Worms were washed in antibody B buffer (3 min× 30 min),
then incubated 1.5 h at room temperature with ALEXA594-
labeled donkey anti-mouse IgG (Molecular Probes) diluted 1:200
in antibody A buffer. After three 30-min washes in antibody B
buffer, worms were counterstained with DAPI (Invitrogen) and
mounted on slides with Prolong Gold Antifade Reagent (Invitro-
gen); images were captured with an Olympus BX51 fluorescence
microscope.
EXPRESSION OF SOD-3::GFP AND PEPCK::GFP FOLLOWED BY PIA
TREATMENT
PIAs were dissolved in DMSO, creating 20× stocks that pro-
duce final PIA concentrations of 1 or 10µM in the agar
plates. These solutions were overlaid on 60-mm dishes previ-
ously seeded with E. coli strain OP50. Adult worms were of strain
TJ374 (zEx374) expressing SOD-3::GFP fusion protein, or strain
BC10543 (sEx10543) expressing a PCK-2(R11A5.4)::GFP fusion
protein. They were synchronized by alkaline hypochlorite lysis
of hermaphrodites, and surviving embryos were transferred to
fresh NGM-agar plates. Young adults (post-L4 molt) were trans-
ferred to NGM-agar plates with PIAs. After 48 h, adult worms
were collected, washed three times in S buffer, and fixed in 1%
formaldehyde. Worms were mounted on slides under a cover-
slip, and fluorescence images were taken using an Olympus BX51
microscope.
IN VIVO PIP3 ASSAY
Wild-type and age-1 mutant worms were collected and washed
in phosphate-free RPMI-1640 medium, then labeled at 20˚C
with 1 mCi/ml [32P]-orthophosphate for 16 h in phosphate-
free RPMI-1640 medium. 32P-labeled worms were then washed
once in phosphate-free RPMI-1640 medium, and lipids were
extracted and separated by thin-layer chromatography accord-
ing to a published procedure (Weinkove et al., 2006). After
autoradiography, spots were scraped from the chromato-
graph and β emissions quantified in a scintillation counter
(Beckman).
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